12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Thursday's intraday session, several healthcare stocks experienced significant movements. Impel Pharmaceuticals (IMPL) saw a dramatic increase of 141.4%, while Entrada Therapeutics (TRDA) faced a sharp decline of 33.1%. Other notable gainers include Conduit Pharmaceuticals (CDT), Telesis Bio (TBIO), AquaBounty Techs (AQB), PaxMedica (PXMD), and Seelos Therapeutics (SEEL). On the losing side, Alterity Therapeutics (ATHE), GRI Bio (GRI), Inspire Veterinary (IVP), Altamira Therapeutics (CYTO), and Mira Pharmaceuticals (MIRA) saw their stock prices fall.

November 23, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Alterity Therapeutics stock decreased by 29.84% to $1.67, with a market cap of $6.7 million.
ATHE's significant stock price decline could reflect negative market sentiment or adverse company news, which may lead to further short-term depreciation.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Altamira Therapeutics shares dropped 18.48% to $0.3, with a market cap of $2.3 million.
CYTO's decrease in stock price could be due to negative investor sentiment or company-specific news, which may result in further short-term declines.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
GRI Bio shares fell 20.83% to $0.79, with a market cap of $2.3 million.
The drop in GRI's stock price suggests bearish sentiment, which could continue in the short term if the negative factors persist.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Inspire Veterinary shares decreased by 19.52% to $0.56, with a market cap of $5.0 million.
IVP's stock price decline indicates a negative market response, potentially leading to further short-term losses if the underlying reasons are not addressed.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Mira Pharmaceuticals stock fell by 17.98% to $3.2, with a market cap of $47.2 million.
MIRA's stock price decline suggests that the market is reacting negatively, which could lead to further short-term downward pressure.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Entrada Therapeutics stock fell by 33.1% to $11.15, with a market cap of $372.0 million.
The significant drop in TRDA's stock price indicates negative sentiment or developments affecting the company. This bearish trend could persist in the short term, leading to potential further declines.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
AquaBounty Techs shares rose by 33.12% to $2.09, with a market cap of $8.0 million.
The increase in AQB's stock price indicates a positive market reaction, which could lead to further short-term gains as investors may continue to buy into the momentum.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Conduit Pharmaceuticals shares increased by 37.69% to $1.79, with a market cap of $130.3 million.
CDT's notable rise in stock price could attract more attention from investors, potentially leading to further short-term gains as the market responds to the positive momentum.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Impel Pharmaceuticals shares surged by 141.4% to $0.77, with a market cap of $18.4 million.
The substantial increase in IMPL's stock price suggests a very positive market reaction, likely due to favorable news or events related to the company. This could lead to increased investor interest and further gains in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
PaxMedica shares increased by 28.12% to $1.02, with a market cap of $1.1 million.
PXMD's rise in stock price, despite a small market cap, could indicate underlying positive factors that may lead to further short-term appreciation.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Seelos Therapeutics shares increased by 28.03% to $0.17, with a market cap of $26.8 million.
SEEL's stock price gain could suggest investor optimism, potentially leading to more short-term increases as the market reacts to the company's positive momentum.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Telesis Bio shares climbed 35.58% to $0.41, with a market cap of $12.1 million.
TBIO's significant stock price increase could be driven by positive news or investor sentiment, suggesting potential for continued upward movement in the short term.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90